Haemonetics vs Stevanato Group S.p.a.
Haemonetics and Stevanato Group S.p.a. are similar in size: $1.33bn and $1.34bn of revenue in their latest fiscal years. Stevanato Group S.p.a. grew faster (12.3% against -2.0%). Stevanato Group S.p.a. kept more of each dollar of sales as profit: a net margin of 11.8% against 7.3%. Stevanato Group S.p.a. carries less debt relative to equity (30.6% against 155.7%).
| Latest fiscal year | HaemoneticsHAE, 2026 | Stevanato Group S.p.a.STVN, 2025 |
|---|---|---|
| Revenue | $1.33bn | $1.34bn |
| Revenue growth | -2.0% | 12.3% |
| Net income | $97.3m | $158m |
| Operating margin | 11.7% | 16.8% |
| Net margin | 7.3% | 11.8% |
| Return on equity | 12.0% | 9.9% |
| Free cash flow | $260m | $25.2m |
| Cash | $245m | $153m |
| Total debt | $1.24bn | $534m |
| Debt to equity | 155.7% | 30.6% |
| Dividend per share | — | — |
| Dividend yield | — | 0.3% |
| Share buybacks | $175m | — |
| Employees | — | — |
| Market value | $5.49bn | $3.97bn |
| Price vs our value range | Above our value range | — |
| Moat score | 62 (Moderate) | — |
| Insider trades, 12 months | 1 buys, 0 sales | 0 buys, 8 sales |